TY - JOUR T1 - The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review. AU - Boyd,Sean, AU - Sheng Loh,Kai, AU - Lynch,Jessie, AU - Alrashed,Dhari, AU - Muzzammil,Saad, AU - Marsh,Hannah, AU - Masoud,Mustafa, AU - Bin Ihsan,Salman, AU - Martin-Loeches,Ignacio, Y1 - 2022/06/08/ PY - 2022/03/30/received PY - 2022/05/10/revised PY - 2022/06/06/accepted PY - 2022/6/23/entrez PY - 2022/6/24/pubmed PY - 2022/6/28/medline KW - COVID-19 KW - DVT (deep vein thrombosis) KW - ICU (intensive care unit) KW - PE (pulmonary embolism) KW - VTE (venous thromboembolism) KW - community-acquired pneumonia KW - influenza JF - Medical sciences (Basel, Switzerland) JO - Med Sci (Basel) VL - 10 IS - 2 N2 - The rate of venous thromboembolism in COVID-19 patients has been reported to be 30% (deep vein thrombosis 20% and pulmonary embolism 18%). This has been shown to be higher in COVID-19 patients admitted to the ICU. Prophylactic anticoagulation may be sufficient at ward level, but not in intensive care. A retrospective chart review was undertaken in a large university hospital. The review included 276 patients from COVID-19 Wave 1, COVID-19 Wave 2, influenza, and community-acquired pneumonia groups. The timeframe included patients admitted between 23 February 2014 and 12 May 2021. Clinical characteristics, outcomes, blood results, rates of venous thromboembolism, and anticoagulation status were recorded. The incidence of venous thromboembolism in COVID-19 Wave 1, COVID-19 Wave 2, influenza, and community-acquired pneumonia was 10.91%, 13.69%, 13.33%, and 6.81%, respectively (p = 0.481). The incidence of pulmonary embolism was 7.27%, 10.95%, 3.33%, and 5.68%, respectively (p = 0.350). The incidence of deep vein thrombosis was 5.45%, 5.48%, 10.00%, and 1.14%, respectively (p = 0.117). Although most patients were prophylactically anticoagulated, venous thromboembolism still occurred. Venous thromboembolism remains an important differential to consider in critically ill COVID-19 patients. The current literature does not advise therapeutic anticoagulation for thromboprophylaxis in the ICU. SN - 2076-3271 UR - https://www.unboundmedicine.com/medline/citation/35736350/The_Incidence_of_Venous_Thromboembolism_in_Critically_Ill_Patients_with_SARS_CoV_2_Infection_Compared_with_Critically_Ill_Influenza_and_Community_Acquired_Pneumonia_Patients:_A_Retrospective_Chart_Review_ DB - PRIME DP - Unbound Medicine ER -